Oncology & Cancer

New treatment offers benefit for hypoxic laryngeal tumors

(HealthDay) -- For patients with squamous cell laryngeal cancer, regional control rates are improved with accelerated radiotherapy (AR) plus carbogen inhalation and nicotinamide (ARCON) treatment compared with AR-alone, with ...

Oncology & Cancer

Study links 23 microRNAs to laryngeal cancer

A Henry Ford Hospital study has identified 23 microRNAs for laryngeal cancer, a discovery that could yield new insight into what causes certain cells to grow and become cancerous tumors in the voice box.

Oncology & Cancer

Head and neck cancer -- what you need to know

It is estimated that 40,000 men and women in the United States will develop head and neck cancer in the coming year. Head and neck cancer involves the cells that line the mucosal surfaces or moist tissue lining in the head ...

page 2 from 2